// App-Quantinova.ai

1801 : Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy

Researchers

Presenter

  • Eric S. Mullins

Principal Investigators

  • Rebecca Geer

  • Megan Metcalf

  • Jeanne Piccola

  • Adam Lane

  • Lee Ann E Conard

  • Tanya Lilliane Kowalczyk Mullins

Medical Centers

  • Cancer and Blood Diseases Institute, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH

  • Univ. of Cincinnati College of Medicine, Cincinnati, OH.

  • Bone Marrow Transplant and Immune Deficiency, Cincinnati Childrens Hospital Medical Center, Cincinnati,

  • Division of Adolescent and Transition Medicine, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Venous thrombosis

  • Gender dysphoria

  • Migraine

  • Obesity

  • Stroke

Biomarkers

  • Plasminogen activator ihnibitor-1

Drug/Treatment

  • FVIII

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved